Eurofins Scient (OTCMKTS:ERFSF) Short Interest Update

Eurofins Scient (OTCMKTS:ERFSF) saw a significant decline in short interest during the month of January. As of January 15th, there was short interest totaling 86,941 shares, a decline of 66.8% from the December 31st total of 261,757 shares. Based on an average daily volume of 27,237 shares, the short-interest ratio is currently 3.2 days. Currently, 0.0% of the shares of the stock are short sold. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily volume of 27,237 shares, the short-interest ratio is currently 3.2 days.

Analysts Set New Price Targets

ERFSF has been the subject of several recent research reports. BNP Paribas Exane upgraded shares of Eurofins Scient to an “outperform” rating in a report on Monday, January 5th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Eurofins Scient in a research report on Wednesday, October 29th. Finally, Citigroup restated a “neutral” rating on shares of Eurofins Scient in a research report on Wednesday, October 22nd. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Eurofins Scient has an average rating of “Moderate Buy”.

Eurofins Scient Stock Performance

Shares of Eurofins Scient stock traded down $0.21 on Wednesday, reaching $85.56. 920 shares of the stock were exchanged, compared to its average volume of 9,859. The company has a current ratio of 1.26, a quick ratio of 1.19 and a debt-to-equity ratio of 0.77. Eurofins Scient has a 1-year low of $48.55 and a 1-year high of $86.20. The business has a fifty day moving average price of $74.62 and a two-hundred day moving average price of $74.28.

Eurofins Scient Company Profile

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.